BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
-16.23%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.45B
AUM Growth
-$125M
(-8%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
10.17%
Top 10 Holdings %
Top 10 Hldgs %
37.98%
Holding
149
New
10
Increased
70
Reduced
43
Closed
11
Top Buys
| 1 |
Align Technology
ALGN
|
$34.4M |
| 2 |
Illumina
ILMN
|
$31.2M |
| 3 |
Intuitive Surgical
ISRG
|
$24.4M |
| 4 |
Teladoc Health
TDOC
|
$24.2M |
| 5 |
Abbott
ABT
|
$15.2M |
Top Sells
| 1 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$15.1M |
| 2 |
Centene
CNC
|
$14.7M |
| 3 |
Edwards Lifesciences
EW
|
$14.6M |
| 4 |
Pacific Biosciences
PACB
|
$13.9M |
| 5 |
SHPG
Shire pic
SHPG
|
$11.6M |
Sector Composition
| 1 | Healthcare | 92.41% |
| 2 | Industrials | 1.04% |
| 3 | Technology | 0.54% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
BioMarin Pharmaceuticals
BMRN
$10.9B
| $3.91M | 0.26% |
45,969
-1,900
| -4% | -$162K |
|
77
Inspire Medical Systems
INSP
$2.55B
| $3.91M | 0.26% |
92,616
+1,920
| +2% | +$81.1K |
|
78
Tandem Diabetes Care
TNDM
$837M
| $3.77M | 0.25% |
99,253
+2,058
| +2% | +$78.2K |
|
79
Incyte
INCY
$16.7B
| $3.73M | 0.25% |
58,650
+6,300
| +12% | +$401K |
|
80
Hologic
HOLX
$14.8B
| $3.7M | 0.24% |
90,000
-271,894
| -75% | -$11.2M |
|
81
Veeva Systems
VEEV
$44.3B
| $3.4M | 0.22% |
38,092
+5,401
| +17% | +$482K |
|
|
MDSO
82
DELISTED
Medidata Solutions, Inc.
MDSO
| $3.32M | 0.22% |
49,211
+12,304
| +33% | +$830K |
|
|
HZNP
83
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.29M | 0.22% |
168,500
-53,178
| -24% | -$1.04M |
|
84
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $3.25M | 0.21% |
358,935
+143,000
| +66% | +$1.29M |
|
85
Ligand Pharmaceuticals
LGND
$3.27B
| $3.24M | 0.21% |
38,264
+20,198
| +112% | +$1.71M |
|
86
Neuronetics
STIM
$219M
| $3.2M | 0.21% |
165,400
+53,493
| +48% | +$1.03M |
|
|
NVRO
87
DELISTED
NEVRO CORP.
NVRO
| $3.17M | 0.21% |
81,438
+1,023
| +1% | +$39.8K |
|
|
CERN
88
DELISTED
Cerner Corp
CERN
| $3.1M | 0.2% |
59,146
| – | – |
|
|
AMED
89
DELISTED
Amedisys
AMED
| $2.95M | 0.19% |
25,204
| – | – |
|
90
Penumbra
PEN
$10.9B
| $2.94M | 0.19% |
24,050
+4,908
| +26% | +$600K |
|
91
Neurocrine Biosciences
NBIX
$13.9B
| $2.86M | 0.19% |
40,050
-1,500
| -4% | -$107K |
|
92
Johnson & Johnson
JNJ
$431B
| $2.58M | 0.17% |
20,000
| – | – |
|
93
Masimo
MASI
$7.77B
| $2.45M | 0.16% |
22,780
+3,304
| +17% | +$355K |
|
|
ICPT
94
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.33M | 0.15% |
23,148
-1,000
| -4% | -$101K |
|
|
CSLT
95
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.3M | 0.15% |
1,059,515
+170,673
| +19% | +$370K |
|
|
AGN
96
DELISTED
Allergan plc
AGN
| $2.14M | 0.14% |
16,000
+3,000
| +23% | +$401K |
|
|
SGEN
97
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.98M | 0.13% |
35,000
-11,950
| -25% | -$677K |
|
98
Exelixis
EXEL
$10.1B
| $1.85M | 0.12% |
+94,000
| New | +$1.85M |
|
99
CVS Health
CVS
$93.5B
| $1.69M | 0.11% |
25,825
+17,825
| +223% | +$1.17M |
|
100
Acadia Pharmaceuticals
ACAD
$4.3B
| $1.55M | 0.1% |
95,800
+38,800
| +68% | +$627K |
|